TSX News -
Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits
RIVER EDGE, NJ–(Marketwired – Aug 8, 2017) – Nephros, Inc. (OTCQB: NEPH) (the “Company”), a commercial stage medical device company […]